Arrivent Biopharma Inc. (AVBP)
Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
24. 42
+0.1
+0.41%
$
929.61M Market Cap
- P/E Ratio
0% Div Yield
165,823 Volume
- Eps
$ 24.32
Previous Close Day Range
23.52 24.64
Year Range
15.47 29.71
Want to track AVBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 79 days
Discover the 3 Best-Performing Biotech IPO Stocks of 2024
Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies.
Marketbeat | 1 year ago
Wall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 27.26%: Read This Before Placing a Bet
The mean of analysts' price targets for ArriVent BioPharma, Inc. (AVBP) points to a 27.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
